Publikationen, an denen er mitarbeitet Bernat Soria Escoms (131)

2023

  1. Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  2. Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention

    BMJ

  3. Rationale for combined therapies in severe-to-critical COVID-19 patients

    Frontiers in Immunology, Vol. 14

  4. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses

    Frontiers in Cell and Developmental Biology, Vol. 11

2022

  1. Considerations for Clinical Use of Mesenchymal Stromal Cells

    Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 51-102

  2. Health and economic burden due to malaria in Peru over 30 years (1990–2019): Findings from the global burden of diseases study 2019

    The Lancet Regional Health - Americas, Vol. 15

  3. Human Omental Mesothelial Cells Impart an Immunomodulatory Landscape Impeding B-and T-Cell Activation

    International Journal of Molecular Sciences, Vol. 23, Núm. 11

  4. Mesenchymal Stromal Cells for COVID-19 Critical Care Patients: A Present Hope

    Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 163-191

  5. Pdx1 Is Transcriptionally Regulated by EGR-1 during Nitric Oxide-Induced Endoderm Differentiation of Mouse Embryonic Stem Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

2021

  1. A new shortened protocol to obtain islet-like cells from hESC-derived ductal cells

    In Vitro Cellular and Developmental Biology - Animal, Vol. 57, Núm. 6, pp. 587-597

  2. Editorial: A Compendium of Recent Research on Stem Cell-Based Therapy for Covid-19

    Frontiers in Cell and Developmental Biology

  3. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

  4. Stemness of human pluripotent cells: Hypoxia-like response induced by low nitric oxide

    Antioxidants, Vol. 10, Núm. 9

2020

  1. AICAR stimulates the pluripotency transcriptional complex in embryonic stem cells mediated by PI3K, GSK3β, and β-Catenin

    ACS Omega, Vol. 5, Núm. 32, pp. 20270-20282

  2. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

  3. Generation of pancreatic islets from stem cells

    Principles of Tissue Engineering (Elsevier), pp. 657-664

  4. Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming

    Frontiers in Immunology, Vol. 11

  5. Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy

    Frontiers in Bioengineering and Biotechnology, Vol. 8

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

  2. Dissecting the brain/islet axis in metabesity

    Genes, Vol. 10, Núm. 5